Overview
Melanos Care is a Deep-Tech biotech platform that develops bio-identical melanin and advanced active ingredients for skincare, focusing on protection, anti-aging, and natural aesthetics. The company offers a melanin-based cream that provides long-lasting UV protection, natural tanning, and anti-aging benefits, utilizing proprietary stem cell technology for cost-effective production. Additionally, they have created a cinnamic acid derivative that effectively reduces melanin content, addressing hyperpigmentation with superior efficacy compared to global market leaders.
Financials
Revenue history
Filing timeliness
1 of 2 financial statements was filed late (for 2024, 2 days late).
- 202513/07/2026
- 202417/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
If the company has a one-person management board, the only member of the management board is authorised to represent the company independently. If the management board consists of two or more members, then: (i) if the amount of the liability incurred or the performance rendered does not exceed PLN 25,000.00, the company may be represented by one person; (ii) if the amount of the liability incurred or the performance rendered exceeds PLN 25,000.00, joint action of two members of the management board or joint action of one member of the management board with a commercial proxy is required to make declarations of will and sign documents on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Liwochage 53 | 26 | $351.16 | 10.1563% |
Marcin Marek Majkaage 54 | 117 | $1,580.23 | 45.7031% |
Konrad Grzegorz Szczukiewiczage 37 | 35 | $472.72 | 13.6719% |
Piotr Antoni Sznelewskiage 57 | 27 | $364.67 | 10.5469% |
Others | 51 | $688.82 | 19.9218% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-11-17.
24 1090 2590 0000 0001 5584 6652
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $546,963.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $5,726$5,726 | Fundacja Klaster Lifescience Kraków | |
| Jan 28, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,857$2,857 | Fundacja Klaster Lifescience Kraków | |
| Dec 15, 2025 | Aid for SMEs for innovation support | $498.3K$498,299 | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-10-01 | Development and validation of an optimised lyophilisation protocol for biological microvesicles (melanosomes and exosomes) | $40,080$40,080 | European Funds for Małopolska 2021-2027 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Change history
| Date | Event | |
|---|---|---|
| 2024-05-14 | Share capital increase (10,000.00 PLN → 10,800.00 PLN) | |
| 2023-10-24 | Entered in the register |
FAQ
Last updated: 2026-07-15